What are the benefits of the ExoDx Prostate Test (EPI)?
The ExoDx Prostate Test provides a risk assessment for finding clinically significant prostate cancer that otherwise relies on biopsy in men with an elevated PSA. Introducing the ExoDx Prostate (EPI) Test. The EPI Test provides a simple, painless, and accurate answer to inform the prostate biopsy decision. If the test result indicates that a “low risk”, then the man and his doctor (using all other clinical information including family history, prior PSA, abnormal DRE) may decide to defer prostate biopsy – avoiding the pain, complications and costs associated with a prostate biopsy. Interested in learning more? Find a physician or ask about our ExoCARES program by calling 1-844-396-7663 Option 3, then Option 2.
Should I Get The ExoDx Prostate Test?
If you are a man over the age of 50 with a prostate specific antigen (PSA) of 2-10 ng/mL and are considering a prostate biopsy, then you should talk to your doctor or health care provider about The ExoDx ProstateTest.
The ExoDx Prostate Test helps physicians and patients make critical decisions about whether or not to proceed to or defer prostate biopsy.
The ExoDx Prostate Test:
- Simple, non-invasive urine test
- Included in the May 2019 NCCN guidelines
- Granted Breakthrough Designation by the FDA
- Covered by Medicare
- Performed in more than 70,000 men
- Proven to avoid almost 30% of biopsies